ClassID:

97314

C07K2319/02 - page 9 - CPC Classification

Classification description:

Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Recent Application in this class:
#2401
20170022567
2017-01-26

High MAST2-affinity polypeptides and uses thereof

#2402
20170022489
2017-01-26

Hybrid polypeptides having cellobiohydrolase activity and polynucleotides encoding same

#2403
20170015746
2017-01-19

DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS

#2404
20170015724
2017-01-19

Growth hormone fusion proteins with growth hormone receptor agonist activity

#2405
20170015720
2017-01-19

Claudin-6-specific immunoreceptors and T cell epitopes

#2406
20170014508
2017-01-19

Chimeric antigen receptor (CAR) signalling system

#2407
20170008947
2017-01-12

Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer

#2408
20170002072
2017-01-05

Compositions and methods for treating cancer

#2409
20170000886
2017-01-05

MESENCHYMAL STEM CELLS FOR TARGETED CANCER THERAPY

#2410
20160367656
2016-12-22

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

#2411
20160362480
2016-12-15

NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE

#2412
20160362471
2016-12-15

Artificial signal peptide

#2413
20160361415
2016-12-15

Methods of Using Interleukin-10 for Treating Diseases and Disorders

#2414
20160355590
2016-12-08

Lym-1 and Lym-2 targeted CAR cell immunotherapy

#2415
20160354462
2016-12-08

Vaccine and therapeutic delivery system

#2416
20160347818
2016-12-01

Compositions and methods for immunomodulation in an organism

#2417
20160346373
2016-12-01

Algal based edible vaccines

#2418
20160340442
2016-11-24

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

#2419
20160333422
2016-11-17

ANTI-NY-BR-1 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

#2420
20160333374
2016-11-17

Pseudotyped lentiviral vectors

#2421
20160333108
2016-11-17

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

#2422
20160333067
2016-11-17

Compositions and methods for immunomodulation in an organism

#2423
20160331826
2016-11-17

Baculovirus display vectors and uses thereof

#2424
20160326265
2016-11-10

Compositions and methods for targeting stromal cells for the treatment of cancer

#2425
20160326256
2016-11-10

Recombinant obligate anaerobic gram-positive bacteria

#2426
20160326220
2016-11-10

SECRETION AND FUNCTIONAL DISPLAY OF CHIMERIC POLYPEPTIDES

#2427
20160324953
2016-11-10

DNA vaccine against virus of Yellow Fever

#2428
20160319035
2016-11-03

PDK1 BINDING MOLECULES AND USES THEREOF

#2429
20160311917
2016-10-27

Human mesothelin chimeric antigen receptors and uses thereof

#2430
20160311910
2016-10-27

Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same

#2431
20160311867
2016-10-27

PESTICIDAL FUSION PROTEIN IMPROVEMENTS

#2432
20160304624
2016-10-20

Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same

#2433
20160304567
2016-10-20

Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria

#2434
20160303225
2016-10-20

Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines

#2435
20160297884
2016-10-13

Chimeric antigen receptors targeting B-cell maturation antigen

#2436
20160297856
2016-10-13

Recombinant host cells and nucleic acid constructs encoding polypeptides having cellulolytic enhancing activity

#2437
20160289294
2016-10-06

Cell

#2438
20160289293
2016-10-06

Cell

#2439
20160282350
2016-09-29

METHODS OF DIAGNOSING CANCER

#2440
20160281105
2016-09-29

PHI-4 polypeptides and methods for their use

#2441
20160280798
2016-09-29

ALK ANTIBODIES, CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND THEIR USE

#2442
20160271245
2016-09-22

Nucleic acids for treatment of allergies

#2443
20160270377
2016-09-22

Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception

#2444
20160264961
2016-09-15

Protease-resistant systems for polypeptide display and methods of making and using thereof

#2445
20160264646
2016-09-15

PRODUCTION OF HUMAN PULMONARY SURFACTANT PROTEIN B IN PLANTS

#2446
20160257762
2016-09-08

Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof

#2447
20160251665
2016-09-01

Cells expressing apolipoprotein E and uses thereof

#2448
20160250313
2016-09-01

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#2449
20160250301
2016-09-01

Long-acting coagulation factors and methods of producing same

#2450
20160237155
2016-08-18

Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteins

#2451
20160237132
2016-08-18

Fusion polypeptides comprising mucin-domain polypeptide linkers

#2452
20160235815
2016-08-18

Composition comprising a mixture of CD95-Fc isoforms

#2453
20160235787
2016-08-18

Epitope Spreading Associated with CAR T-Cells

#2454
20160229896
2016-08-11

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#2455
20160228547
2016-08-11

CHIMERIC ANTIGEN RECEPTOR TARGETING OF TUMOR ENDOTHELIUM

#2456
20160222174
2016-08-04

Methods and compositions for synthesizing improved silk fibers

#2457
20160220701
2016-08-04

Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders

#2458
20160208012
2016-07-21

Compositions and methods for treatment of cancer

#2459
20160200824
2016-07-14

Anti CD30 chimeric antigen receptor and its use

#2460
20160194404
2016-07-07

Compositions and methods for treatment of cancer

#2461
20160176979
2016-06-23

Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

#2462
20160176952
2016-06-23

Phage displaying system expressing single chain antibody

#2463
20160168262
2016-06-16

Antibodies to MUC16 and methods of use thereof

#2464
20160168260
2016-06-16

Method of treating cancer with an EGFR targeted immunomodulatory fusion protein

#2465
20160168198
2016-06-16

SIGNAL SEQUENCE FOR PROTEIN EXPRESSION IN PICHIA PASTORIS

#2466
20160165860
2016-06-16

Domain 5 of CD163 for use in antiviral compositions against PRRS, and transgenic animals

#2467
20160159907
2016-06-09

Compositions and methods for treatment of cancer

#2468
20160153020
2016-06-02

Methods for producing sialylated therapeutic proteins

#2469
20160152680
2016-06-02

Targeted therapeutic proteins

#2470
20160151490
2016-06-02

Methods and compositions for treating cancer

#2471
20160145593
2016-05-26

Heat stable keratinase and use thereof

#2472
20160145303
2016-05-26

Strong Secretory Signal Peptide Enhancing Small Peptide Motifs and the Use Thereof

#2473
20160130563
2016-05-12

Compositions and methods for enhancing virus replication

#2474
20160130357
2016-05-12

Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same

#2475
20160130355
2016-05-12

Compositions and methods for treatment of cancer

#2476
20160130315
2016-05-12

Tumor tissue-penetrating peptide specific to neuropilin and fusion protein having same peptide fused therein

#2477
20160122777
2016-05-05

Influenza virus-like particle production in plants

#2478
20160122731
2016-05-05

Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses

#2479
20160114030
2016-04-28

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

#2480
20160108429
2016-04-21

-Prom mediated surface expression of avidin/streptavidin

#2481
20160108407
2016-04-21

Surface display of functional proteins in a broad range of gram negative bacteria

#2482
20160108099
2016-04-21

Vectors encoding rod-derived cone viability factor

#2483
20160102128
2016-04-14

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

#2484
20160096902
2016-04-07

Anti-CD19 scFv (FMC63) polypeptide

#2485
20160096875
2016-04-07

Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

#2486
20160083775
2016-03-24

Compositions and methods for identifying enzyme and transport protein inhibitors

#2487
20160083707
2016-03-24

Plant lectins as carriers of associated drug substances into animal and human cells

#2488
20160082079
2016-03-24

Wnt antagonist and methods of treatment and screening

#2489
20160076051
2016-03-17

Expression process

#2490
20160075784
2016-03-17

CS1-specific chimeric antigen receptor engineered immune effector cells

#2491
20160075754
2016-03-17

Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

#2492
20160060640
2016-03-03

Coryneform bacterium and method for producing heterologous fusion proteins

#2493
20160060637
2016-03-03

Improved Gene Targeting and Nucleic Acid Carrier Molecule, In Particular for Use in Plants

#2494
20160052994
2016-02-25

Modified laminin containing collagen binding molecule and use thereof

#2495
20160052983
2016-02-25

Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide

#2496
20160051651
2016-02-25

Treatment of cancer using a CLL-1 chimeric antigen receptor

#2497
20160046968
2016-02-18

Strain secreting fatty acids by phospholipase and method for producing fatty acids using it

#2498
20160046721
2016-02-18

Antibodies and methods for treating estrogen receptor-associated diseases

#2499
20160046676
2016-02-18

Fusion polypeptides and vaccines

#2500
20160045591
2016-02-18

Vaccine and therapeutic delivery system

#2501
20160038584
2016-02-11

Vaccines for human papilloma virus and methods for using the same

#2502
20160032265
2016-02-04

Thermostable β-xylosidase belonging to GH family 3

#2503
20160031960
2016-02-04

Compositions and methods of use for treating metabolic disorders

#2504
20160031947
2016-02-04

Cupredoxin derived transport agents and methods of use thereof

#2505
20160022806
2016-01-28

Influenza nucleic acid molecules and vaccines made therefrom

#2506
20160017021
2016-01-21

TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME

#2507
20160017012
2016-01-21

Delivery of card protein as therapy for occular inflammation

#2508
20160009783
2016-01-14

Oligomers for TNF superfamily inhibition

#2509
20150368292
2015-12-24

METHOD OF PRODUCING A PROTEIN

#2510
20150366174
2015-12-24

Non-human animals having a humanized programmed cell death 1 gene

#2511
20150361148
2015-12-17

Amyloid beta expression constructs and uses therefor

#2512
20150307856
2015-10-29

Beta-hexosyl-transferases and uses thereof

#2513
20150307588
2015-10-29

Endoglin polypeptides and uses thereof

#2514
20150306217
2015-10-29

Vaccines against HPV

#2515
20150299292
2015-10-22

Methods and compositions for modulating Toso activity

#2516
20150291991
2015-10-15

METHODS AND COMPOSITIONS RELATING TO AMYLOIDOGENIC POLYPEPTIDES

#2517
20150291669
2015-10-15

Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof

#2518
20150291664
2015-10-15

BIOTINYLATED PROTEIN

#2519
20150290313
2015-10-15

Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

#2520
20150276762
2015-10-01

Collagen-derived recombinant proteins with von Willebrand factor-binding activity

#2521
20150266937
2015-09-24

Vaccine for treatment of tautopathy

#2522
20150265699
2015-09-24

Recombinant novirhabdovirus usable as an antigen vector

#2523
20150252080
2015-09-10

Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof

#2524
20150239976
2015-08-27

Internalizing ErbB2 antibodies

#2525
20150239945
2015-08-27

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

#2526
20150239939
2015-08-27

Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer

#2527
20150232862
2015-08-20

Nucleic acid vectors and uses thereof

#2528
20150232578
2015-08-20

HYBRID PROTEINS AND USES THEREOF

#2529
20150225482
2015-08-13

Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics

#2530
20150225475
2015-08-13

Composition comprising a mixture of CD95-Fc isoforms and methods of producing same

#2531
20150225467
2015-08-13

NOVEL FAR RED FLUORESCENT PROTEIN

#2532
20150212064
2015-07-30

DEGRANULATION INDICATOR AND METHODS OF USE THEREOF

#2533
20150202263
2015-07-23

Neurturin molecules

#2534
20150197551
2015-07-16

Methods and compositions for modulating Toso activity

#2535
20150196656
2015-07-16

Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof

#2536
20150191710
2015-07-09

Intracellular protein delivery

#2537
20150191525
2015-07-09

OX40L fusion protein for the immunotherapy of tumors of veterinary animals

#2538
20150183858
2015-07-02

Peptide-hinge-free flexible antibody-like molecule

#2539
20150183837
2015-07-02

Immunogenic compositions and methods of use thereof

#2540
20150175670
2015-06-25

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#2541
20150167030
2015-06-18

Recombinant cellulosome complex and uses thereof

#2542
20150166974
2015-06-18

Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof

#2543
20150166633
2015-06-18

Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof

#2544
20150166613
2015-06-18

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#2545
20150166612
2015-06-18

Vaccines and methods for using the same

#2546
20150157735
2015-06-11

Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery

#2547
20150148246
2015-05-28

Surface anchored light chain bait antibody display system

#2548
20150141331
2015-05-21

Long-acting polypeptides and methods of producing and administering same

#2549
20150141329
2015-05-21

Neurturin molecules

#2550
20150140003
2015-05-21

Anti-alpha-synuclein antibodies and methods of use

#2551
20150139995
2015-05-21

Methods and compositions for modulating toso activity

#2552
20150139945
2015-05-21

Compositions and methods for immunomodulation in an organism

#2553
20150139943
2015-05-21

Chimeric receptors and uses thereof in immune therapy

#2554
20150099708
2015-04-09

Wnt compositions and therapeutic uses of such compositions

#2555
20150099297
2015-04-09

CHIMERIC PROTEINS FOR TREATMENT OF DISEASES

#2556
20150093357
2015-04-02

Compositions and methods for Immunomodulation in an organism

#2557
20150087046
2015-03-26

Spider silk fusion protein structures without repetitive fragment for binding to an organic target

#2558
20150086589
2015-03-26

Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof

#2559
20150079084
2015-03-19

Protein inhibitors to complement and VEGF pathways and methods of use thereof

#2560
20150074842
2015-03-12

Fungal resistant plants expressing hydrophobin

#2561
20150072937
2015-03-12

Chimeric peptides for the regulation of GTPases

#2562
20150056197
2015-02-26

VACCINES AGAINST HPV

#2563
20150037880
2015-02-05

DNA encoding canine monomeric CRP and expression vector containing the DNA

#2564
20150031624
2015-01-29

Anti-mesothelin chimeric antigen receptors

#2565
20150031618
2015-01-29

Muteins of αm lipocalin and method of production therefor

#2566
20150024003
2015-01-22

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

#2567
20150010936
2015-01-08

Modified leucine dehydrogenase

#2568
20150005371
2015-01-01

Treating cardiovascular or renal diseases

#2569
20140377859
2014-12-25

NPP1 fusion proteins

#2570
20140377827
2014-12-25

Hybrid polypeptides having cellobiohydrolase activity and polynucleotides encoding same

#2571
20140371429
2014-12-18

Methods and composition for secretion of heterologous polypeptides

#2572
20140370543
2014-12-18

Expression process

#2573
20140370045
2014-12-18

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

#2574
20140356392
2014-12-04

Modulators of MYC and methods of using the same

#2575
20140345004
2014-11-20

Cells producing glycoproteins having altered glycosylation patterns and method and use thereof

#2576
20140341907
2014-11-20

Bispecific antibody fragments for neurological disease proteins and methods of use

#2577
20140336367
2014-11-13

Recombinant NEL-like (NELL) protein production

#2578
20140336117
2014-11-13

Growth hormone receptor antagonists

#2579
20140335097
2014-11-13

Expression vectors for cell-surface expression of polypeptides comprising a transmembrane domain of glycophorin A

#2580
20140335087
2014-11-13

Aspartyl-tRNA synthetase-Fc conjugates

#2581
20140328821
2014-11-06

Vectors encoding rod-derived cone viability factor

#2582
20140328812
2014-11-06

Chimeric receptors with 4-1BB stimulatory signaling domain

#2583
20140315822
2014-10-23

High MAST2-affinity polypeptides and uses thereof

#2584
20140287480
2014-09-25

HBV polymerase mutants

#2585
20140286986
2014-09-25

Polypeptides having immunoactivating activity and methods of producing the same

#2586
20140256000
2014-09-11

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#2587
20140255441
2014-09-11

VLPS containing ligands and methods related thereto

#2588
20140234962
2014-08-21

Ligands modified by circular permutation as agonists and antagonists

#2589
20140220637
2014-08-07

Method for secretory production of protein

#2590
20140201855
2014-07-17

Mutant luciferases

#2591
20140199305
2014-07-17

Protein comprising truncated form of extracellular region protein of Frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein

#2592
20140186387
2014-07-03

Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof

#2593
20140178931
2014-06-26

mTOR ligands and polynucleotides encoding mTOR ligands

#2594
20140154285
2014-06-05

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#2595
20140154280
2014-06-05

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#2596
20140154213
2014-06-05

Recombinant vector for producing and secreting peptide or protein of interest by propionibacteria and applications thereof

#2597
20140142278
2014-05-22

Methods for producing secreted polypeptides having biological activity

#2598
20140142046
2014-05-22

Wnt compositions and therapeutic uses of such compositions

#2599
20140135383
2014-05-15

SDF-1 delivery for treating ischemic tissue

#2600
20140127806
2014-05-08

Modified laminin and use thereof

#2601
20140105861
2014-04-17

Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders

#2602
20140099299
2014-04-10

Methods and compositions for cytomegalovirus IL-10 protein

#2603
20140082766
2014-03-20

Antimicrobial peptides and uses thereof

#2604
20140080178
2014-03-20

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#2605
20140073767
2014-03-13

Protein complexes and methods of manufacturing bispecific antibodies using the protein complexes

#2606
20140073009
2014-03-13

Methods for producing secreted polypeptides

#2607
20140056934
2014-02-27

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#2608
20140056867
2014-02-27

Targeted therapeutic proteins

#2609
20140050756
2014-02-20

OprF/I fusion proteins, their preparation and use

#2610
20140037554
2014-02-06

Cupredoxin derived transport agents and methods of use thereof

#2611
20140017792
2014-01-16

Vector particles for targeting CD34+ cells

#2612
20140011981
2014-01-09

Expression and secretion system

#2613
20140011739
2014-01-09

Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery

#2614
20130338067
2013-12-19

Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide

#2615
20130337507
2013-12-19

Xylanases, nucleic acids encoding them and methods for making and using them

#2616
20130337039
2013-12-19

Internalizing erbB2 antibodies

#2617
20130336925
2013-12-19

Fusion polypeptides comprising mucin-domain polypeptide linkers

#2618
20130336924
2013-12-19

Ligands modified by circular permutation as agonists and antagonists

#2619
20130330784
2013-12-12

Temperature-stable β-pyranosidase

#2620
20130324477
2013-12-05

Peptides that modulate complex SASPase-FLG2

#2621
20130323813
2013-12-05

Peptides for the specific binding of RNA targets

#2622
20130316379
2013-11-28

Moesin fragments associated with immune thrombocytopenia

#2623
20130303597
2013-11-14

SDF-1 delivery for treating ischemic tissue

#2624
20130302308
2013-11-14

Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses

#2625
20130288372
2013-10-31

Fibronectin based scaffold domain proteins that bind IL-23

#2626
20130287748
2013-10-31

Use of chimeric antigen receptor-modified T-cells to treat cancer

#2627
20130281671
2013-10-24

Systems for factor VIII processing and methods thereof

#2628
20130281371
2013-10-24

Methods for increasing red blood cell levels comprising administering BMP9

#2629
20130281356
2013-10-24

Methods and compositions for modulating Toso activity

#2630
20130280221
2013-10-24

Interleukin 15 as selectable marker for gene transfer in lymphocytes

#2631
20130273021
2013-10-17

NPP1 fusion proteins

#2632
20130251712
2013-09-26

Covalently dimerized bivalent binding agents

#2633
20130230925
2013-09-05

Molecular switches and methods for making and using the same

#2634
20130217616
2013-08-22

Chimeric inhibitor molecules of complement activation

#2635
20130209513
2013-08-15

Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

#2636
20130209395
2013-08-15

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

#2637
20130189289
2013-07-25

Vaccine for treatment of tautopathy

#2638
20130171152
2013-07-04

Antibodies to MUC16 and methods of use thereof

#2639
20130164845
2013-06-27

Compositions and Methods for the Delivery of Biologically Active RNAs

#2640
20130164820
2013-06-27

Protease screening methods and proteases identified thereby

#2641
20130164766
2013-06-27

Isolation and application of BAD-1 for diagnosing infections with

#2642
20130142826
2013-06-06

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

#2643
20130136767
2013-05-30

Compositions, methods and uses for poxvirus elements in vaccine constructs

#2644
20130136741
2013-05-30

Soluble tandem selectin glycoprotein ligand molecules

#2645
20130122546
2013-05-16

Signal peptide, and use thereof for producing recombinant proteins

#2646
20130116165
2013-05-09

Light-activated fusion proteins and uses therefor

#2647
20130089898
2013-04-11

Biocatalysts and methods for the synthesis of ()-3-(1-aminoethyl)-phenol

#2648
20130084602
2013-04-04

SOLUBLE EXPRESSION OF BULKY FOLDED ACTIVE PROTEINS

#2649
20130084291
2013-04-04

Compositions and methods for increasing serum half-life

#2650
20130059785
2013-03-07

Gene and polypeptide sequences

#2651
20130058871
2013-03-07

METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY

#2652
20130045871
2013-02-21

ENGINEERING CORRECTLY FOLDED ANTIBODIES USING INNER MEMBRANE DISPLAY OF TWIN-ARGININE TRANSLOCATION INTERMEDIATES

#2653
20130035287
2013-02-07

TRANSIENT IMMORTALIZATION

#2654
20130034551
2013-02-07

Wnt antagonists and methods of treatment and screening

#2655
20130029844
2013-01-31

Polynucleotides encoding cyclotides having nematocidal activity

#2656
20130022637
2013-01-24

Recombinant baculovirus vaccine

#2657
20130017574
2013-01-17

Methods and compositions for enhanced expression and secretion of proteins

#2658
20130011426
2013-01-10

Recombinant vaccines and use thereof

#2659
20130011338
2013-01-10

Cupredoxin derived transport agents and methods of use thereof

#2660
20130004489
2013-01-03

Activin-actriia antagonists and uses for treating multiple myeloma

#2661
20120329725
2012-12-27

Chimeric peptides for the regulation of GTPases

#2662
20120328699
2012-12-27

METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS

#2663
20120315676
2012-12-13

Endoglucanases

#2664
20120309936
2012-12-06

Reducing the immunogenicity of fusion proteins

#2665
20120308603
2012-12-06

DNA vaccine against virus of yellow fever

#2666
20120308551
2012-12-06

Protease screening methods and proteases identified thereby

#2667
20120301945
2012-11-29

PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY

#2668
20120295327
2012-11-22

Targeted therapeutic proteins

#2669
20120295274
2012-11-22

Reporter vector presenting extracellular binding capacity to metallic compounds

#2670
20120289586
2012-11-15

SDF-1 delivery for treating ischemic tissue

#2671
20120289585
2012-11-15

SDF-1 delivery for treating ischemic tissue

#2672
20120288913
2012-11-15

NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS

#2673
20120283315
2012-11-08

SDF-1 DELIVERY FOR TREATING ISCHEMIC TISSUE

#2674
20120282287
2012-11-08

Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

#2675
20120276148
2012-11-01

Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein

#2676
20120276142
2012-11-01

NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IGE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME

#2677
20120276072
2012-11-01

Constructs for expressing lysosomal polypeptides

#2678
20120264144
2012-10-18

Method for binding a recombinant polypeptide to a carrier

#2679
20120251570
2012-10-04

Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of DNA and chimeric virus vaccines

#2680
20120225454
2012-09-06

Synthetic operon

#2681
20120214200
2012-08-23

Prokaryotic expression construct

#2682
20120195924
2012-08-02

Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses

#2683
20120189658
2012-07-26

Chimeric influenza virus-like particles comprising hemagglutinin

#2684
20120178912
2012-07-12

Receptor activator of NF-kappaB

#2685
20120178132
2012-07-12

Endoglucanases

#2686
20120177598
2012-07-12

Method for treating cancer by administering IL-15 and IL-15Ralpha complexes

#2687
20120172253
2012-07-05

Compositions and methods for identifying enzyme and transport protein inhibitors

#2688
20120171719
2012-07-05

Use of SUC2 gene in for sucrose utilization

#2689
20120171253
2012-07-05

Fibromodulin peptide

#2690
20120157666
2012-06-21

INTERFERON-LIKE PROTEINS AND USES THEREOF

#2691
20120156732
2012-06-21

Methods for synthesizing sugar chains using β1,3-N-acetylglucosaminyltransferase

#2692
20120142090
2012-06-07

Protein expression system

#2693
20120141452
2012-06-07

Targeted therapeutic proteins

#2694
20120129710
2012-05-24

METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS

#2695
20120122191
2012-05-17

Methods for producing secreted polypeptides

#2696
20120121602
2012-05-17

Proteins

#2697
20120114688
2012-05-10

VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS

#2698
20120108790
2012-05-03

Truncated somatostatin receptors

#2699
20120093863
2012-04-19

HCV vaccines and methods for using the same

#2700
20120093862
2012-04-19

Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens